Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

PHASE3CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

December 31, 2001

Study Completion Date

June 30, 2013

Conditions

HIV Infections

Interventions

DRUG

Viread (tenofovir disoproxil fumarate)

Tenofovir DF 300 mg tablets once daily

DRUG

Sustiva (Efavirenz)

efavirenz capsules 600 mg once daily

DRUG

Epivir (Lamivudine)

lamivudine 150 mg tablets twice daily

DRUG

Zerit (Stavudine) Placebo

stavudine placebo capsules twice daily